| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 5.52e-24 | 46 | 101 | 15 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 3.38e-14 | 188 | 101 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.30e-11 | 12 | 101 | 6 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 KRT4 COL11A1 COL11A2 COL19A1 NUP214 COL22A1 COL24A1 POM121 COL21A1 TMEM30A BSN POM121B COL1A1 COL1A2 | 3.01e-09 | 891 | 101 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 1.44e-05 | 156 | 101 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.66e-04 | 25 | 101 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.36e-04 | 27 | 101 | 3 | GO:0008139 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 COL24A1 C6orf15 COL1A1 COL1A2 | 2.74e-11 | 377 | 98 | 16 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 COL24A1 C6orf15 COL1A1 COL1A2 | 2.85e-11 | 378 | 98 | 16 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 COL24A1 C6orf15 COL1A1 COL1A2 | 2.97e-11 | 379 | 98 | 16 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.68e-09 | 12 | 98 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.78e-08 | 18 | 98 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 7.36e-08 | 76 | 98 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 1.18e-05 | 161 | 98 | 7 | GO:0071230 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 2.18e-05 | 177 | 98 | 7 | GO:0071229 | |
| GeneOntologyBiologicalProcess | response to amino acid | 5.07e-05 | 202 | 98 | 7 | GO:0043200 | |
| GeneOntologyBiologicalProcess | muscle tissue development | COL3A1 BCL9L COL11A1 COL19A1 HLX TSC1 BCL9 TBX18 GLI1 FGF2 DMRTA2 | 6.88e-05 | 558 | 98 | 11 | GO:0060537 |
| GeneOntologyBiologicalProcess | response to acid chemical | 1.08e-04 | 228 | 98 | 7 | GO:0001101 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | COL2A1 COL5A1 COL11A1 HLX TSC1 TBX18 CELSR1 GLI1 RBM14 FGF2 MAPK7 PCDH8 | 1.42e-04 | 713 | 98 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | connective tissue development | 2.31e-04 | 343 | 98 | 8 | GO:0061448 | |
| GeneOntologyBiologicalProcess | head development | COL2A1 COL3A1 COL4A1 GAK AKNA TSC1 NR2F1 PRDM8 TTBK1 GLI1 FGF2 DMRTA2 COL1A1 | 4.04e-04 | 919 | 98 | 13 | GO:0060322 |
| GeneOntologyBiologicalProcess | embryo development | COL2A1 COL3A1 COL5A1 COL11A1 HLX TSC1 TBX18 CELSR1 SH3PXD2A GLI1 TTLL4 RBM14 EHMT1 FGF2 MAPK7 PCDH8 COL1A1 | 4.05e-04 | 1437 | 98 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 ADGRB2 TSC1 ADAM8 TBX18 GLI1 AMOTL1 FGF2 MAPK7 VAV2 COL1A1 COL1A2 | 4.22e-04 | 1442 | 98 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | tendon development | 4.62e-04 | 7 | 98 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | osteoclast fusion | 4.62e-04 | 7 | 98 | 2 | GO:0072675 | |
| GeneOntologyBiologicalProcess | regulation of clathrin coat assembly | 4.62e-04 | 7 | 98 | 2 | GO:1905443 | |
| GeneOntologyBiologicalProcess | synaptic vesicle uncoating | 4.62e-04 | 7 | 98 | 2 | GO:0016191 | |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 5.77e-21 | 21 | 100 | 11 | GO:0098644 |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.26e-19 | 88 | 100 | 15 | GO:0005581 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 3.60e-14 | 12 | 100 | 7 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 3.60e-14 | 12 | 100 | 7 | GO:0098643 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 5.64e-11 | 332 | 100 | 15 | GO:0005788 |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.46e-09 | 5 | 100 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 C6orf15 COL1A1 COL1A2 | 4.40e-09 | 530 | 100 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | collagen type IV trimer | 7.34e-09 | 6 | 100 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 ZAN COL22A1 COL24A1 COL21A1 C6orf15 COL1A1 COL1A2 | 1.33e-08 | 656 | 100 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 ZAN COL22A1 COL24A1 COL21A1 C6orf15 COL1A1 COL1A2 | 1.39e-08 | 658 | 100 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.40e-08 | 8 | 100 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.40e-08 | 8 | 100 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.40e-08 | 8 | 100 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 KRT4 COL11A1 COL11A2 AKNA TSC1 NCKAP5L TTLL4 PAWR PLK1 DYNC1H1 COL1A1 COL1A2 | 3.03e-06 | 1187 | 100 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type I trimer | 2.27e-05 | 2 | 100 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | basement membrane | 2.66e-05 | 122 | 100 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 COL3A1 COL5A1 KRT4 COL11A1 COL11A2 AKNA TSC1 NCKAP5L TTLL4 PAWR PLK1 DYNC1H1 COL1A1 COL1A2 | 4.72e-04 | 1179 | 100 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | dense core granule membrane | 9.94e-04 | 10 | 100 | 2 | GO:0032127 | |
| GeneOntologyCellularComponent | nuclear pore | 1.41e-03 | 101 | 100 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.71e-03 | 13 | 100 | 2 | GO:1990907 | |
| HumanPheno | Arterial rupture | 6.73e-08 | 8 | 30 | 4 | HP:0025019 | |
| HumanPheno | Cervical insufficiency | 7.35e-07 | 4 | 30 | 3 | HP:0030009 | |
| HumanPheno | Neonatal short-limb short stature | 9.40e-07 | 14 | 30 | 4 | HP:0008921 | |
| HumanPheno | Bell-shaped thorax | 1.06e-06 | 33 | 30 | 5 | HP:0001591 | |
| HumanPheno | Osteoarthritis | 1.60e-06 | 65 | 30 | 6 | HP:0002758 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.83e-06 | 5 | 30 | 3 | HP:0007964 | |
| HumanPheno | Short limb dwarfism | 3.56e-06 | 19 | 30 | 4 | HP:0003505 | |
| HumanPheno | Dwarfism | 5.46e-06 | 21 | 30 | 4 | HP:0001516 | |
| HumanPheno | Molluscoid pseudotumors | 6.35e-06 | 7 | 30 | 3 | HP:0000993 | |
| HumanPheno | Dumbbell-shaped long bone | 6.35e-06 | 7 | 30 | 3 | HP:0000947 | |
| HumanPheno | Uterine prolapse | 6.35e-06 | 7 | 30 | 3 | HP:0000139 | |
| HumanPheno | Genital hernia | 1.01e-05 | 8 | 30 | 3 | HP:0100823 | |
| HumanPheno | Dermal translucency | 1.56e-05 | 27 | 30 | 4 | HP:0010648 | |
| HumanPheno | Cigarette-paper scars | 2.15e-05 | 10 | 30 | 3 | HP:0001073 | |
| HumanPheno | Joint subluxation | 2.76e-05 | 31 | 30 | 4 | HP:0032153 | |
| HumanPheno | Abnormal tibia morphology | 2.94e-05 | 107 | 30 | 6 | HP:0002992 | |
| HumanPheno | Biconcave flattened vertebrae | 3.35e-05 | 2 | 30 | 2 | HP:0003321 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 3.35e-05 | 2 | 30 | 2 | HP:0006524 | |
| HumanPheno | Absent ossification of calvaria | 3.35e-05 | 2 | 30 | 2 | HP:0005623 | |
| HumanPheno | Dyspepsia | 3.35e-05 | 2 | 30 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 3.35e-05 | 2 | 30 | 2 | HP:0006756 | |
| HumanPheno | Severe generalized osteoporosis | 3.35e-05 | 2 | 30 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 3.35e-05 | 2 | 30 | 2 | HP:0005005 | |
| HumanPheno | Arterial dissection | 3.91e-05 | 12 | 30 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 3.91e-05 | 12 | 30 | 3 | HP:0004947 | |
| HumanPheno | Pierre-Robin sequence | 4.01e-05 | 34 | 30 | 4 | HP:0000201 | |
| HumanPheno | Bladder diverticulum | 5.05e-05 | 36 | 30 | 4 | HP:0000015 | |
| HumanPheno | Abnormal uterine cervix morphology | 5.07e-05 | 13 | 30 | 3 | HP:0012888 | |
| HumanPheno | Atrophic scars | 5.64e-05 | 37 | 30 | 4 | HP:0001075 | |
| HumanPheno | Fragile skin | 5.64e-05 | 37 | 30 | 4 | HP:0001030 | |
| HumanPheno | Soft, doughy skin | 6.42e-05 | 14 | 30 | 3 | HP:0001027 | |
| HumanPheno | Focal cortical dysplasia | 8.00e-05 | 15 | 30 | 3 | HP:0032046 | |
| HumanPheno | Tibial bowing | 8.51e-05 | 41 | 30 | 4 | HP:0002982 | |
| HumanPheno | Hypoplastic ischia | 9.81e-05 | 16 | 30 | 3 | HP:0003175 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 1.00e-04 | 3 | 30 | 2 | HP:0006201 | |
| HumanPheno | Anterior lenticonus | 1.00e-04 | 3 | 30 | 2 | HP:0011501 | |
| HumanPheno | Popcorn calcification | 1.00e-04 | 3 | 30 | 2 | HP:6000871 | |
| HumanPheno | Vulvar neoplasm | 1.00e-04 | 3 | 30 | 2 | HP:0030416 | |
| HumanPheno | Subcutaneous spheroids | 1.00e-04 | 3 | 30 | 2 | HP:0025014 | |
| HumanPheno | Precordial pain | 1.00e-04 | 3 | 30 | 2 | HP:0032141 | |
| HumanPheno | Lens dislocation | 1.03e-04 | 43 | 30 | 4 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 1.03e-04 | 43 | 30 | 4 | HP:0001083 | |
| HumanPheno | Disproportionate short stature | 1.18e-04 | 137 | 30 | 6 | HP:0003498 | |
| HumanPheno | Premature rupture of membranes | 1.19e-04 | 17 | 30 | 3 | HP:0001788 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 1.25e-04 | 86 | 30 | 5 | HP:0006499 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.90e-04 | 94 | 30 | 5 | HP:0006500 | |
| HumanPheno | Enlarged thorax | 1.90e-04 | 94 | 30 | 5 | HP:0100625 | |
| HumanPheno | Femoral hernia | 1.96e-04 | 20 | 30 | 3 | HP:0100541 | |
| HumanPheno | Shoulder dislocation | 1.96e-04 | 20 | 30 | 3 | HP:0003834 | |
| HumanPheno | Generalized osteoporosis | 1.96e-04 | 20 | 30 | 3 | HP:0040160 | |
| HumanPheno | short, dumbbell appearance of long bones | 2.00e-04 | 4 | 30 | 2 | HP:0005061 | |
| HumanPheno | Dumbbell-shaped femur | 2.00e-04 | 4 | 30 | 2 | HP:0006375 | |
| HumanPheno | Piezogenic pedal papules | 2.00e-04 | 4 | 30 | 2 | HP:0025509 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 2.00e-04 | 4 | 30 | 2 | HP:0003023 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 2.00e-04 | 4 | 30 | 2 | HP:0010590 | |
| HumanPheno | Incisional hernia | 2.00e-04 | 4 | 30 | 2 | HP:0004872 | |
| HumanPheno | Dilatation of the cerebral artery | 2.02e-04 | 51 | 30 | 4 | HP:0004944 | |
| HumanPheno | Thoracic hypoplasia | 2.17e-04 | 153 | 30 | 6 | HP:0005257 | |
| HumanPheno | Finger joint hypermobility | 2.18e-04 | 52 | 30 | 4 | HP:0006094 | |
| HumanPheno | Thin ribs | 2.18e-04 | 52 | 30 | 4 | HP:0000883 | |
| HumanPheno | Vitreoretinopathy | 2.63e-04 | 22 | 30 | 3 | HP:0007773 | |
| HumanPheno | Cortical dysplasia | 2.90e-04 | 56 | 30 | 4 | HP:0002539 | |
| HumanPheno | Mutism | 2.90e-04 | 56 | 30 | 4 | HP:0002300 | |
| HumanPheno | Abnormal anterior eye segment morphology | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 ESS2 CYP27A1 MAFA TSC1 NR2F1 EPS15L1 AASS EHMT1 COL1A1 COL1A2 | 2.96e-04 | 1450 | 30 | 18 | HP:0004328 |
| HumanPheno | Limb pain | 3.11e-04 | 57 | 30 | 4 | HP:0009763 | |
| HumanPheno | Abnormality of hand joint mobility | 3.11e-04 | 57 | 30 | 4 | HP:0006256 | |
| HumanPheno | Abnormality of tibial epiphyses | 3.32e-04 | 5 | 30 | 2 | HP:0006508 | |
| HumanPheno | Hypermobility of interphalangeal joints | 3.32e-04 | 5 | 30 | 2 | HP:0005620 | |
| HumanPheno | Basilar impression | 3.32e-04 | 5 | 30 | 2 | HP:0005758 | |
| HumanPheno | Flat face | 3.34e-04 | 106 | 30 | 5 | HP:0012368 | |
| HumanPheno | Disproportionate short-limb short stature | 3.81e-04 | 109 | 30 | 5 | HP:0008873 | |
| HumanPheno | Biconcave vertebral bodies | 3.89e-04 | 25 | 30 | 3 | HP:0004586 | |
| HumanPheno | Abnormal ischium morphology | 4.90e-04 | 27 | 30 | 3 | HP:0003174 | |
| HumanPheno | Crumpled long bones | 4.96e-04 | 6 | 30 | 2 | HP:0006367 | |
| HumanPheno | Cupped ribs | 6.08e-04 | 29 | 30 | 3 | HP:0000887 | |
| HumanPheno | Small joint hypermobilty | 6.48e-04 | 69 | 30 | 4 | HP:0430046 | |
| HumanPheno | Mitral valve prolapse | 6.64e-04 | 123 | 30 | 5 | HP:0001634 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 6.72e-04 | 30 | 30 | 3 | HP:0005743 | |
| HumanPheno | Short scapulae | 6.72e-04 | 30 | 30 | 3 | HP:0000906 | |
| HumanPheno | Hypoplastic scapulae | 6.72e-04 | 30 | 30 | 3 | HP:0000882 | |
| HumanPheno | Aortic root aneurysm | 6.84e-04 | 70 | 30 | 4 | HP:0002616 | |
| HumanPheno | Platyspondyly | 6.89e-04 | 124 | 30 | 5 | HP:0000926 | |
| HumanPheno | Pulp calcification | 6.91e-04 | 7 | 30 | 2 | HP:0003771 | |
| HumanPheno | Otosclerosis | 6.91e-04 | 7 | 30 | 2 | HP:0000362 | |
| HumanPheno | Lens luxation | 6.91e-04 | 7 | 30 | 2 | HP:0012019 | |
| HumanPheno | Phalangeal dislocation | 6.91e-04 | 7 | 30 | 2 | HP:0006243 | |
| HumanPheno | Short femur | 7.41e-04 | 31 | 30 | 3 | HP:0003097 | |
| HumanPheno | Aplasia/Hypoplasia of the scapulae | 7.41e-04 | 31 | 30 | 3 | HP:0006713 | |
| HumanPheno | Myopia | COL2A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 NR2F1 COL1A2 | 7.63e-04 | 447 | 30 | 9 | HP:0000545 |
| HumanPheno | Glossoptosis | 8.15e-04 | 32 | 30 | 3 | HP:0000162 | |
| HumanPheno | Atypical scarring of skin | 8.45e-04 | 74 | 30 | 4 | HP:0000987 | |
| HumanPheno | Skin nodule | 9.16e-04 | 132 | 30 | 5 | HP:0200036 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 9.19e-04 | 8 | 30 | 2 | HP:0003262 | |
| HumanPheno | Blepharochalasis | 9.19e-04 | 8 | 30 | 2 | HP:0010749 | |
| HumanPheno | Pulmonary artery aneurysm | 9.19e-04 | 8 | 30 | 2 | HP:0004937 | |
| HumanPheno | Abnormal limb epiphysis morphology | 1.12e-03 | 138 | 30 | 5 | HP:0006505 | |
| HumanPheno | Papule | 1.15e-03 | 209 | 30 | 6 | HP:0200034 | |
| HumanPheno | Abnormality of the epiphysis of the femoral head | 1.30e-03 | 83 | 30 | 4 | HP:0010574 | |
| HumanPheno | Vascular dilatation | 1.34e-03 | 215 | 30 | 6 | HP:0002617 | |
| HumanPheno | Dilatation of the ascending aorta | 1.36e-03 | 84 | 30 | 4 | HP:0005111 | |
| MousePheno | perinatal lethality | COL2A1 COL4A1 GAK COL11A1 HLX MAP3K12 NR2F1 TBX18 CELSR1 SLC18A2 SH3PXD2A AMOTL1 ZNF516 CPEB4 DMRTA2 DYNC1H1 CNTFR CBX2 COL1A1 COL1A2 | 4.78e-06 | 1130 | 81 | 20 | MP:0002081 |
| MousePheno | aphagia | 9.55e-06 | 129 | 81 | 7 | MP:0001438 | |
| MousePheno | postnatal lethality, incomplete penetrance | COL2A1 COL3A1 COL4A1 KRT4 COL19A1 AKNA TSC1 DNAJC6 EPS15L1 AMOTL1 CPEB4 EHMT1 CBX2 COL1A1 | 2.68e-05 | 669 | 81 | 14 | MP:0011086 |
| MousePheno | absent gastric milk in neonates | 2.71e-05 | 102 | 81 | 6 | MP:0009546 | |
| MousePheno | neonatal lethality | COL2A1 GAK COL11A1 NR2F1 TBX18 SLC18A2 SH3PXD2A AMOTL1 ZNF516 CPEB4 DMRTA2 DYNC1H1 CNTFR CBX2 COL1A1 | 4.70e-05 | 799 | 81 | 15 | MP:0002058 |
| MousePheno | fusion of atlas and occipital bones | 5.14e-05 | 13 | 81 | 3 | MP:0010728 | |
| MousePheno | perinatal lethality, complete penetrance | COL2A1 GAK COL11A1 HLX NR2F1 TBX18 CELSR1 SLC18A2 AMOTL1 ZNF516 DYNC1H1 CNTFR COL1A1 COL1A2 | 5.30e-05 | 712 | 81 | 14 | MP:0011089 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | COL2A1 COL3A1 COL4A1 KRT4 COL19A1 AKNA TSC1 DNAJC6 NR2F1 EPS15L1 SLC18A2 SH3PXD2A AMOTL1 CPEB4 EHMT1 DMRTA2 CBX2 COL1A1 | 6.02e-05 | 1124 | 81 | 18 | MP:0011112 |
| MousePheno | abnormal synovial joint morphology | 8.13e-05 | 124 | 81 | 6 | MP:0030804 | |
| MousePheno | abnormal joint mobility | 1.20e-04 | 17 | 81 | 3 | MP:0008069 | |
| MousePheno | postnatal lethality | COL2A1 COL3A1 COL4A1 COL4A2 KRT4 COL19A1 AKNA TSC1 DNAJC6 MAP3K12 EPS15L1 SLC18A2 AMOTL1 CPEB4 EHMT1 CBX2 COL1A1 | 1.30e-04 | 1084 | 81 | 17 | MP:0002082 |
| MousePheno | buphthalmos | 1.97e-04 | 4 | 81 | 2 | MP:0009274 | |
| MousePheno | abnormal synaptic vesicle morphology | 2.13e-04 | 51 | 81 | 4 | MP:0004769 | |
| MousePheno | abnormal heart left ventricle morphology | COL4A2 COL11A1 ARHGAP40 MAP3K12 PRDM8 SH3PXD2A MAPK7 VAV2 COL1A2 | 2.76e-04 | 369 | 81 | 9 | MP:0003921 |
| MousePheno | neonatal lethality, incomplete penetrance | 3.24e-04 | 298 | 81 | 8 | MP:0011088 | |
| MousePheno | abnormal compact bone lamellar structure | 3.28e-04 | 5 | 81 | 2 | MP:0010970 | |
| MousePheno | decreased tendon stiffness | 3.28e-04 | 5 | 81 | 2 | MP:0003098 | |
| MousePheno | anterior polar cataract | 3.28e-04 | 5 | 81 | 2 | MP:0010259 | |
| MousePheno | abnormal limb joint morphology | 3.93e-04 | 25 | 81 | 3 | MP:0030805 | |
| MousePheno | abnormal dermal layer morphology | 4.03e-04 | 108 | 81 | 5 | MP:0001243 | |
| MousePheno | abnormal joint morphology | COL2A1 COL4A2 COL11A1 COL11A2 TBX18 SH3PXD2A EHMT1 COL1A1 COL1A2 | 4.70e-04 | 397 | 81 | 9 | MP:0002932 |
| MousePheno | micromelia | 4.90e-04 | 6 | 81 | 2 | MP:0008736 | |
| MousePheno | abnormal tendon stiffness | 4.90e-04 | 6 | 81 | 2 | MP:0003097 | |
| MousePheno | polar cataract | 4.90e-04 | 6 | 81 | 2 | MP:0010258 | |
| MousePheno | abnormal tendon physiology | 4.90e-04 | 6 | 81 | 2 | MP:0030802 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 4.96e-04 | 27 | 81 | 3 | MP:0008438 | |
| MousePheno | abnormal suckling behavior | 4.96e-04 | 113 | 81 | 5 | MP:0001436 | |
| MousePheno | abnormal hippocampal commissure morphology | 5.53e-04 | 28 | 81 | 3 | MP:0008221 | |
| Domain | Collagen | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.68e-19 | 85 | 95 | 15 | IPR008160 |
| Domain | Collagen | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.68e-19 | 85 | 95 | 15 | PF01391 |
| Domain | Fib_collagen_C | 5.40e-17 | 11 | 95 | 8 | IPR000885 | |
| Domain | COLFI | 5.40e-17 | 11 | 95 | 8 | PF01410 | |
| Domain | NC1_FIB | 5.40e-17 | 11 | 95 | 8 | PS51461 | |
| Domain | Fib_collagen_C | 5.40e-17 | 11 | 95 | 8 | PD002078 | |
| Domain | COLFI | 5.40e-17 | 11 | 95 | 8 | SM00038 | |
| Domain | Laminin_G | COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 CELSR1 CNTNAP5 COL21A1 | 1.34e-11 | 58 | 95 | 9 | IPR001791 |
| Domain | TSPN | 1.61e-11 | 23 | 95 | 7 | SM00210 | |
| Domain | C4 | 9.35e-09 | 6 | 95 | 4 | SM00111 | |
| Domain | - | 9.35e-09 | 6 | 95 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 9.35e-09 | 6 | 95 | 4 | IPR001442 | |
| Domain | C4 | 9.35e-09 | 6 | 95 | 4 | PF01413 | |
| Domain | NC1_IV | 9.35e-09 | 6 | 95 | 4 | PS51403 | |
| Domain | - | COL5A1 COL11A1 COL11A2 COL19A1 COL24A1 CELSR1 CNTNAP5 COL21A1 | 2.81e-08 | 95 | 95 | 8 | 2.60.120.200 |
| Domain | Laminin_G_2 | 4.93e-08 | 40 | 95 | 6 | PF02210 | |
| Domain | ConA-like_dom | COL5A1 COL11A1 COL11A2 COL19A1 ZAN COL22A1 COL24A1 CELSR1 CNTNAP5 COL21A1 | 1.70e-07 | 219 | 95 | 10 | IPR013320 |
| Domain | LamG | 2.84e-06 | 44 | 95 | 5 | SM00282 | |
| Domain | BCL9_beta-catenin-bd_dom | 2.56e-05 | 2 | 95 | 2 | IPR024670 | |
| Domain | BCL9 | 2.56e-05 | 2 | 95 | 2 | PF11502 | |
| Domain | Bcl-9 | 2.56e-05 | 2 | 95 | 2 | IPR015668 | |
| Domain | VWFC_1 | 3.27e-05 | 36 | 95 | 4 | PS01208 | |
| Domain | VWC | 4.06e-05 | 38 | 95 | 4 | SM00214 | |
| Domain | VWFC_2 | 4.06e-05 | 38 | 95 | 4 | PS50184 | |
| Domain | LAM_G_DOMAIN | 4.06e-05 | 38 | 95 | 4 | PS50025 | |
| Domain | VWF_dom | 6.06e-05 | 42 | 95 | 4 | IPR001007 | |
| Domain | TF_fork_head_CS_2 | 8.70e-05 | 46 | 95 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 9.48e-05 | 47 | 95 | 4 | IPR018122 | |
| Domain | FH | 1.12e-04 | 49 | 95 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.12e-04 | 49 | 95 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.12e-04 | 49 | 95 | 4 | PS00658 | |
| Domain | Fork_head_dom | 1.12e-04 | 49 | 95 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 1.12e-04 | 49 | 95 | 4 | PS50039 | |
| Domain | Forkhead | 1.12e-04 | 49 | 95 | 4 | PF00250 | |
| Domain | - | 1.53e-04 | 4 | 95 | 2 | 3.30.1120.30 | |
| Domain | POLO_box_1 | 1.53e-04 | 4 | 95 | 2 | IPR033701 | |
| Domain | POLO_box_dom | 2.53e-04 | 5 | 95 | 2 | IPR000959 | |
| Domain | VWC | 3.81e-04 | 28 | 95 | 3 | PF00093 | |
| Domain | PTEN_C2 | 7.03e-04 | 8 | 95 | 2 | SM01326 | |
| Domain | PTEN_C2 | 7.03e-04 | 8 | 95 | 2 | PF10409 | |
| Domain | C2_TENSIN | 7.03e-04 | 8 | 95 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 7.03e-04 | 8 | 95 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 7.03e-04 | 8 | 95 | 2 | IPR014020 | |
| Domain | PPASE_TENSIN | 9.00e-04 | 9 | 95 | 2 | PS51181 | |
| Domain | GAIN_dom_N | 1.37e-03 | 11 | 95 | 2 | IPR032471 | |
| Domain | GAIN | 1.37e-03 | 11 | 95 | 2 | PF16489 | |
| Domain | CTDL_fold | 2.17e-03 | 107 | 95 | 4 | IPR016187 | |
| Domain | HormR | 7.12e-03 | 25 | 95 | 2 | SM00008 | |
| Domain | AT_hook | 8.27e-03 | 27 | 95 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.27e-03 | 27 | 95 | 2 | IPR017956 | |
| Domain | HRM | 8.88e-03 | 28 | 95 | 2 | PF02793 | |
| Domain | Ser/Thr_kinase_AS | 9.78e-03 | 357 | 95 | 6 | IPR008271 | |
| Domain | S_TKc | 1.00e-02 | 359 | 95 | 6 | SM00220 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.14e-24 | 44 | 70 | 15 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.57e-21 | 67 | 70 | 15 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL1A1 COL1A2 | 5.43e-21 | 41 | 70 | 13 | MM15538 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 FGF2 COL1A1 COL1A2 | 1.74e-20 | 32 | 70 | 12 | MM14924 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.91e-19 | 90 | 70 | 15 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL1A1 COL1A2 | 1.88e-18 | 61 | 70 | 13 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL1A1 COL1A2 | 1.90e-17 | 53 | 70 | 12 | MM14566 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL1A1 COL1A2 | 4.12e-17 | 76 | 70 | 13 | MM14573 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 FGF2 COL1A1 COL1A2 | 7.78e-17 | 59 | 70 | 12 | M27218 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL24A1 COL1A1 COL1A2 | 1.20e-16 | 61 | 70 | 12 | M27103 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL1A1 COL1A2 | 2.24e-16 | 64 | 70 | 12 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 6.38e-16 | 50 | 70 | 11 | MM14796 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 COL24A1 COL21A1 SH3PXD2A FGF2 COL1A1 COL1A2 | 4.12e-15 | 300 | 70 | 18 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 ADAM8 COL1A1 COL1A2 | 1.01e-14 | 114 | 70 | 13 | MM14571 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 1.65e-14 | 46 | 70 | 10 | M198 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 FGF2 COL1A1 COL1A2 | 6.51e-14 | 74 | 70 | 11 | M160 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 SH3PXD2A FGF2 COL1A1 COL1A2 | 1.02e-13 | 258 | 70 | 16 | MM14572 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 ADAM8 COL1A1 COL1A2 | 1.52e-13 | 140 | 70 | 13 | M587 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 7.91e-13 | 66 | 70 | 10 | M18 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.31e-12 | 30 | 70 | 8 | M27772 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.63e-12 | 19 | 70 | 7 | MM15512 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A6 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 9.65e-12 | 84 | 70 | 10 | M7098 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.05e-11 | 41 | 70 | 8 | M27778 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.82e-11 | 15 | 70 | 6 | M27161 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.02e-10 | 30 | 70 | 7 | MM15517 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL1A1 COL1A2 | 1.18e-10 | 76 | 70 | 9 | MM14867 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL1A1 COL1A2 | 1.18e-10 | 76 | 70 | 9 | M27219 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.13e-10 | 18 | 70 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.13e-10 | 18 | 70 | 6 | MM14882 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL1A1 COL1A2 | 3.29e-10 | 85 | 70 | 9 | M16441 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.42e-10 | 20 | 70 | 6 | MM15061 | |
| Pathway | WP_FOCAL_ADHESION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A6 COL5A1 COL11A1 COL11A2 MAPK7 COL1A1 COL1A2 | 1.83e-09 | 187 | 70 | 11 | MM15913 |
| Pathway | KEGG_FOCAL_ADHESION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A6 COL5A1 COL11A1 COL11A2 VAV2 COL1A1 COL1A2 | 3.52e-09 | 199 | 70 | 11 | M7253 |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.83e-09 | 79 | 70 | 8 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL11A1 COL11A2 EPS15L1 FGF2 MAPK7 VAV2 COL1A1 COL1A2 | 1.39e-08 | 418 | 70 | 14 | MM15587 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL2A1 COL3A1 COL4A1 COL4A2 COL4A6 COL5A1 COL11A1 COL11A2 TSC1 FGF2 COL1A1 COL1A2 | 2.64e-08 | 302 | 70 | 12 | M39719 |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.88e-08 | 19 | 70 | 5 | M27221 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.93e-08 | 38 | 70 | 6 | MM14969 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.76e-08 | 67 | 70 | 7 | MM15345 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL11A1 COL11A2 COL24A1 EPS15L1 FGF2 MAPK7 VAV2 COL1A1 COL1A2 | 3.91e-08 | 532 | 70 | 15 | M27870 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.49e-08 | 42 | 70 | 6 | M7169 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL2A1 COL3A1 COL4A1 COL4A2 COL4A6 COL5A1 COL11A1 COL11A2 TSC1 FGF2 COL1A1 COL1A2 | 6.11e-08 | 326 | 70 | 12 | MM15917 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.14e-07 | 10 | 70 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.14e-07 | 10 | 70 | 4 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.79e-07 | 11 | 70 | 4 | M15422 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.94e-07 | 27 | 70 | 5 | M27217 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.68e-07 | 12 | 70 | 4 | MM1526 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.58e-07 | 57 | 70 | 6 | MM14713 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.85e-07 | 13 | 70 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.85e-07 | 13 | 70 | 4 | M12950 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.98e-07 | 58 | 70 | 6 | M2049 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.37e-07 | 14 | 70 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.37e-07 | 14 | 70 | 4 | M6487 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.55e-07 | 63 | 70 | 6 | M11187 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.30e-07 | 15 | 70 | 4 | MM14922 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.17e-06 | 43 | 70 | 5 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.17e-06 | 43 | 70 | 5 | M53 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.54e-06 | 20 | 70 | 4 | M15394 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.41e-06 | 47 | 70 | 5 | MM14925 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.60e-06 | 23 | 70 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.60e-06 | 23 | 70 | 4 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.40e-06 | 261 | 70 | 9 | MM15676 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 7.49e-06 | 55 | 70 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 9.76e-06 | 58 | 70 | 5 | MM15149 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.04e-05 | 28 | 70 | 4 | MM15957 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.39e-05 | 30 | 70 | 4 | M27216 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.71e-05 | 65 | 70 | 5 | MM15147 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.32e-05 | 339 | 70 | 9 | M39736 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.45e-05 | 40 | 70 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.91e-05 | 41 | 70 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.41e-05 | 42 | 70 | 4 | MM15039 | |
| Pathway | WP_FOCAL_ADHESION | 5.68e-05 | 199 | 70 | 7 | M39402 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.94e-05 | 43 | 70 | 4 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.95e-05 | 84 | 70 | 5 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.46e-05 | 47 | 70 | 4 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.46e-05 | 47 | 70 | 4 | MM14939 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 9.07e-05 | 18 | 70 | 3 | M39421 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 9.98e-05 | 49 | 70 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.08e-04 | 50 | 70 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.17e-04 | 51 | 70 | 4 | MM15151 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.24e-04 | 98 | 70 | 5 | M27152 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.36e-04 | 53 | 70 | 4 | M27212 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL3A1 COL4A1 COL4A2 DOK1 COL4A5 COL5A1 KRT4 MAPK7 VAV2 | 1.74e-04 | 502 | 70 | 10 | MM14537 |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.93e-04 | 58 | 70 | 4 | MM14736 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.52e-04 | 114 | 70 | 5 | MM15361 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 3.78e-04 | 69 | 70 | 4 | M48052 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.22e-04 | 71 | 70 | 4 | M27394 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.32e-04 | 30 | 70 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.32e-04 | 30 | 70 | 3 | MM15812 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 4.69e-04 | 73 | 70 | 4 | MM14948 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 5.02e-04 | 7 | 70 | 2 | M48265 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL3A1 COL4A1 COL4A2 DOK1 COL4A5 COL5A1 MAPK7 VAV2 AGAP2 | 5.15e-04 | 575 | 70 | 10 | M29853 |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 5.25e-04 | 32 | 70 | 3 | M29579 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.74e-04 | 77 | 70 | 4 | M27226 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 5.75e-04 | 33 | 70 | 3 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 6.28e-04 | 34 | 70 | 3 | M27041 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 6.68e-04 | 8 | 70 | 2 | M48236 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 6.85e-04 | 35 | 70 | 3 | M27320 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 6.85e-04 | 35 | 70 | 3 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 6.85e-04 | 35 | 70 | 3 | M773 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL24A1 COL21A1 COL1A1 COL1A2 | 1.75e-16 | 135 | 102 | 13 | 28675934 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | COL4A5 ZNF628 ZNF316 ADGRB2 AKNA NUP214 BCL9 MBD6 C6orf132 PPP1R26 PRR12 EPS15L1 CELSR1 SUGP2 GLI1 TTLL4 ZNF516 EHMT1 OGDHL DMWD ESPL1 PRRT4 DYNC1H1 CBX2 COL1A1 | 1.13e-15 | 1105 | 102 | 25 | 35748872 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A2 COL1A1 COL1A2 | 2.84e-15 | 62 | 102 | 10 | 28344315 |
| Pubmed | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL1A1 COL1A2 | 5.35e-15 | 175 | 102 | 13 | 28071719 | |
| Pubmed | 1.53e-14 | 8 | 102 | 6 | 1377218 | ||
| Pubmed | 4.57e-14 | 9 | 102 | 6 | 9878537 | ||
| Pubmed | 4.57e-14 | 9 | 102 | 6 | 8900172 | ||
| Pubmed | 7.41e-14 | 19 | 102 | 7 | 15689378 | ||
| Pubmed | 6.97e-13 | 25 | 102 | 7 | 19180518 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.18e-12 | 6 | 102 | 5 | 17029294 | |
| Pubmed | 1.18e-12 | 6 | 102 | 5 | 21467034 | ||
| Pubmed | 1.18e-12 | 6 | 102 | 5 | 9101290 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.18e-12 | 6 | 102 | 5 | 8563024 | |
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 1.18e-12 | 6 | 102 | 5 | 3571333 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 2.69e-12 | 15 | 102 | 6 | 9832566 | |
| Pubmed | 4.29e-12 | 16 | 102 | 6 | 17881772 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 1.09e-11 | 8 | 102 | 5 | 20059976 | |
| Pubmed | 1.09e-11 | 8 | 102 | 5 | 18816857 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.09e-11 | 8 | 102 | 5 | 10970885 | |
| Pubmed | 1.09e-11 | 8 | 102 | 5 | 3997552 | ||
| Pubmed | 1.09e-11 | 8 | 102 | 5 | 10382266 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A6 COL5A1 COL19A1 COL24A1 COL21A1 COL1A1 COL1A2 | 3.04e-11 | 153 | 102 | 10 | 25037231 | |
| Pubmed | 4.89e-11 | 10 | 102 | 5 | 9415455 | ||
| Pubmed | 4.89e-11 | 10 | 102 | 5 | 2446864 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 6.97e-11 | 4 | 102 | 4 | 17683922 | |
| Pubmed | 6.97e-11 | 4 | 102 | 4 | 12874293 | ||
| Pubmed | 1.36e-10 | 50 | 102 | 7 | 23658023 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.53e-10 | 12 | 102 | 5 | 12180907 | |
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 1.54e-10 | 27 | 102 | 6 | 12192060 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.82e-10 | 86 | 102 | 8 | 28327460 | |
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 3.48e-10 | 5 | 102 | 4 | 14758483 | |
| Pubmed | 3.48e-10 | 5 | 102 | 4 | 15365990 | ||
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 2426947 | ||
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 1.04e-09 | 6 | 102 | 4 | 27092474 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 16192629 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 1.04e-09 | 6 | 102 | 4 | 10534397 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 17876790 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 1.04e-09 | 6 | 102 | 4 | 19275937 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 1.04e-09 | 6 | 102 | 4 | 9506531 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 1.04e-09 | 6 | 102 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 1.04e-09 | 6 | 102 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 1.04e-09 | 6 | 102 | 4 | 6389236 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 12225806 | ||
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 10722718 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 1.04e-09 | 6 | 102 | 4 | 9673377 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 11732842 | ||
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 1.04e-09 | 6 | 102 | 4 | 22492985 | |
| Pubmed | 1.65e-09 | 39 | 102 | 6 | 33580754 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL24A1 COL1A1 COL1A2 | 1.71e-09 | 167 | 102 | 9 | 22159717 | |
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 2.42e-09 | 7 | 102 | 4 | 8006028 | |
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 10416788 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 11711546 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 23273220 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 1724753 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 FGF2 COL1A1 COL1A2 | 4.40e-09 | 186 | 102 | 9 | 20673868 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 FGF2 COL1A1 COL1A2 | 4.40e-09 | 186 | 102 | 9 | 20452482 | |
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 9164858 | ||
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 29422532 | ||
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 4.84e-09 | 8 | 102 | 4 | 8530406 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 4.84e-09 | 8 | 102 | 4 | 11867580 | |
| Pubmed | 7.99e-09 | 24 | 102 | 5 | 25344368 | ||
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 8.69e-09 | 9 | 102 | 4 | 12412011 | |
| Pubmed | 8.69e-09 | 9 | 102 | 4 | 12101409 | ||
| Pubmed | Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. | 1.23e-08 | 26 | 102 | 5 | 21367821 | |
| Pubmed | 1.44e-08 | 10 | 102 | 4 | 9136074 | ||
| Pubmed | 1.44e-08 | 10 | 102 | 4 | 14559231 | ||
| Pubmed | RNF169 COL11A1 ESS2 ZNF316 SRCIN1 COL22A1 PPP1R26 COL24A1 EPS15L1 NKD2 AMOTL1 ZNF516 CBX2 COL1A2 | 1.50e-08 | 689 | 102 | 14 | 36543142 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.57e-08 | 97 | 102 | 7 | 27559042 | |
| Pubmed | 2.21e-08 | 29 | 102 | 5 | 22972626 | ||
| Pubmed | 2.21e-08 | 29 | 102 | 5 | 34929174 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 2.26e-08 | 11 | 102 | 4 | 7500359 | |
| Pubmed | 2.26e-08 | 11 | 102 | 4 | 14998921 | ||
| Pubmed | 2.26e-08 | 11 | 102 | 4 | 2745554 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 23546968 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 6386565 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 34691289 | ||
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 2.45e-08 | 3 | 102 | 3 | 17453912 | |
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 30273997 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 17662583 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 15141750 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 2.45e-08 | 3 | 102 | 3 | 24088220 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 2.45e-08 | 3 | 102 | 3 | 2010058 | |
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 36553626 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 34205850 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 17024418 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 34009784 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 2.45e-08 | 3 | 102 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 2.45e-08 | 3 | 102 | 3 | 1879336 | |
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 12200454 | ||
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 26406420 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 3.39e-08 | 12 | 102 | 4 | 15837576 | |
| Pubmed | 3.39e-08 | 12 | 102 | 4 | 16024816 | ||
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 4.88e-08 | 13 | 102 | 4 | 16884697 | |
| Pubmed | 4.88e-08 | 13 | 102 | 4 | 7957066 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 4.88e-08 | 13 | 102 | 4 | 21173153 | |
| Pubmed | 6.82e-08 | 14 | 102 | 4 | 19858219 | ||
| Pubmed | 6.82e-08 | 14 | 102 | 4 | 28809397 | ||
| Pubmed | 6.82e-08 | 14 | 102 | 4 | 30459452 | ||
| Pubmed | 6.82e-08 | 14 | 102 | 4 | 12878203 | ||
| Interaction | TOP3B interactions | COL4A5 ZNF628 ZNF316 ADGRB2 AKNA NUP214 BCL9 MBD6 C6orf132 PPP1R26 PRR12 EPS15L1 CELSR1 SUGP2 GLI1 TTLL4 ZNF516 CPEB4 RBM14 EHMT1 OGDHL LSM14B DMWD ESPL1 PRRC2A PRRT4 DYNC1H1 CBX2 COL1A1 | 4.81e-11 | 1470 | 99 | 29 | int:TOP3B |
| Interaction | MMP9 interactions | 1.31e-09 | 67 | 99 | 8 | int:MMP9 | |
| Interaction | C1QTNF1 interactions | 2.98e-09 | 47 | 99 | 7 | int:C1QTNF1 | |
| Interaction | LAIR2 interactions | 4.04e-09 | 49 | 99 | 7 | int:LAIR2 | |
| Interaction | PDGFA interactions | 9.85e-09 | 32 | 99 | 6 | int:PDGFA | |
| Interaction | COLGALT2 interactions | 3.81e-08 | 67 | 99 | 7 | int:COLGALT2 | |
| Interaction | DCN interactions | 6.35e-08 | 43 | 99 | 6 | int:DCN | |
| Interaction | CD93 interactions | 8.41e-08 | 45 | 99 | 6 | int:CD93 | |
| Interaction | TGFBI interactions | 1.27e-07 | 25 | 99 | 5 | int:TGFBI | |
| Interaction | MMP2 interactions | 2.36e-07 | 87 | 99 | 7 | int:MMP2 | |
| Interaction | MAG interactions | 2.79e-07 | 29 | 99 | 5 | int:MAG | |
| Interaction | BGN interactions | 3.34e-07 | 30 | 99 | 5 | int:BGN | |
| Interaction | SPARC interactions | 7.88e-07 | 65 | 99 | 6 | int:SPARC | |
| Interaction | FBLN2 interactions | 8.63e-07 | 66 | 99 | 6 | int:FBLN2 | |
| Interaction | HABP2 interactions | 1.59e-06 | 18 | 99 | 4 | int:HABP2 | |
| Interaction | COL8A2 interactions | 1.90e-06 | 42 | 99 | 5 | int:COL8A2 | |
| Interaction | OSM interactions | 2.50e-06 | 20 | 99 | 4 | int:OSM | |
| Interaction | THBS1 interactions | 3.08e-06 | 127 | 99 | 7 | int:THBS1 | |
| Interaction | PDGFB interactions | 4.72e-06 | 88 | 99 | 6 | int:PDGFB | |
| Interaction | P4HA1 interactions | 1.62e-05 | 298 | 99 | 9 | int:P4HA1 | |
| Interaction | COL4A2 interactions | 3.40e-05 | 75 | 99 | 5 | int:COL4A2 | |
| Interaction | COL1A2 interactions | 4.11e-05 | 78 | 99 | 5 | int:COL1A2 | |
| Interaction | ISL1 interactions | 4.83e-05 | 41 | 99 | 4 | int:ISL1 | |
| Interaction | FXR2 interactions | TSC1 NUP214 POM121 NKD2 GLI1 CPEB4 RBM14 LSM14B ZBTB3 PRRC2A | 5.05e-05 | 430 | 99 | 10 | int:FXR2 |
| Interaction | FGF7 interactions | 6.15e-05 | 16 | 99 | 3 | int:FGF7 | |
| Interaction | TIMP2 interactions | 6.69e-05 | 277 | 99 | 8 | int:TIMP2 | |
| Interaction | PLOD1 interactions | 9.66e-05 | 292 | 99 | 8 | int:PLOD1 | |
| Interaction | MEX3A interactions | COL3A1 BCL9L AMOTL1 CPEB4 FGF2 TMEM30A PRRC2A DYNC1H1 COL1A2 | 1.15e-04 | 384 | 99 | 9 | int:MEX3A |
| Interaction | MAPRE3 interactions | 1.41e-04 | 230 | 99 | 7 | int:MAPRE3 | |
| Interaction | SAA1 interactions | 1.44e-04 | 54 | 99 | 4 | int:SAA1 | |
| Interaction | SERPINE2 interactions | 1.65e-04 | 56 | 99 | 4 | int:SERPINE2 | |
| Interaction | ARHGEF19 interactions | 2.16e-04 | 60 | 99 | 4 | int:ARHGEF19 | |
| Interaction | MAPRE1 interactions | NUP214 NUP42 NCKAP5L DNAJC6 TTBK1 MAST4 PLK1 POM121B PRRC2A DYNC1H1 | 2.18e-04 | 514 | 99 | 10 | int:MAPRE1 |
| Interaction | DTX2 interactions | 2.23e-04 | 330 | 99 | 8 | int:DTX2 | |
| Interaction | MATN2 interactions | 2.38e-04 | 113 | 99 | 5 | int:MATN2 | |
| Interaction | PLOD3 interactions | 2.88e-04 | 183 | 99 | 6 | int:PLOD3 | |
| Interaction | COL5A1 interactions | 2.95e-04 | 65 | 99 | 4 | int:COL5A1 | |
| Interaction | FMR1 interactions | TSC1 BCL9 CNTNAP5 CPEB4 RBM14 BSN ZBTB3 PRRC2A DYNC1H1 AGAP2 | 3.05e-04 | 536 | 99 | 10 | int:FMR1 |
| Interaction | COL5A2 interactions | 3.83e-04 | 29 | 99 | 3 | int:COL5A2 | |
| Interaction | BMI1 interactions | COL5A1 SUGP2 CPEB4 RBM14 SLTM EHMT1 PAWR LSM14B PRRC2A DYNC1H1 CBX2 | 3.90e-04 | 659 | 99 | 11 | int:BMI1 |
| Interaction | YWHAE interactions | TSC1 SRCIN1 MBD6 NCKAP5L C6orf132 MAST4 NKD2 SH3PXD2A AASS AMOTL1 RBM14 PAWR MAPK7 DMWD PRRC2A DYNC1H1 | 3.94e-04 | 1256 | 99 | 16 | int:YWHAE |
| Cytoband | 9q21.11 | 6.02e-07 | 30 | 102 | 4 | 9q21.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.67e-05 | 423 | 102 | 7 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 9.15e-05 | 325 | 102 | 6 | chr9q34 | |
| Cytoband | 9q34.1 | 8.15e-04 | 19 | 102 | 2 | 9q34.1 | |
| Cytoband | Xq22 | 1.10e-03 | 22 | 102 | 2 | Xq22 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.79e-26 | 46 | 65 | 15 | 490 |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 3.51e-04 | 8 | 65 | 2 | 837 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.30e-03 | 15 | 65 | 2 | 26 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 5.08e-26 | 44 | 102 | 15 | M3005 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL1A1 COL1A2 | 5.15e-24 | 43 | 102 | 14 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 2.16e-13 | 275 | 102 | 15 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL1A1 COL1A2 | 2.86e-12 | 270 | 102 | 14 | MM17057 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.59e-08 | 74 | 102 | 7 | M13547 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.01e-08 | 81 | 102 | 7 | M39253 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 8.91e-08 | 29 | 102 | 5 | MM17055 | |
| Coexpression | GU_PDEF_TARGETS_UP | 3.49e-07 | 71 | 102 | 6 | M3955 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 4.36e-07 | 1026 | 102 | 17 | M5889 |
| Coexpression | PASINI_SUZ12_TARGETS_DN | COL3A1 COL4A5 COL5A1 COL11A1 SH3PXD2A AMOTL1 TMEM30A PAWR COL1A1 COL1A2 | 4.50e-07 | 316 | 102 | 10 | M2293 |
| Coexpression | KANG_AR_TARGETS_UP | 4.95e-07 | 17 | 102 | 4 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 4.95e-07 | 17 | 102 | 4 | M2223 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | COL3A1 COL4A5 COL5A1 COL11A1 SH3PXD2A AMOTL1 TMEM30A PAWR COL1A1 COL1A2 | 5.50e-07 | 323 | 102 | 10 | MM1066 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.09e-06 | 47 | 102 | 5 | M7585 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.19e-06 | 200 | 102 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 ADAM8 COL24A1 FGF2 COL1A1 COL1A2 | 1.73e-06 | 1008 | 102 | 16 | MM17056 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.81e-06 | 23 | 102 | 4 | M48001 | |
| Coexpression | HATADA_METHYLATED_IN_LUNG_CANCER_UP | COL2A1 COL5A1 CYP27A1 HLX ZBTB47 PRDM8 CNTNAP5 CCDC86 COL1A1 COL1A2 | 2.21e-06 | 377 | 102 | 10 | M19508 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 TBX18 COL21A1 AMOTL1 COL1A1 COL1A2 | 2.67e-06 | 385 | 102 | 10 | M39264 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.41e-06 | 162 | 102 | 7 | M45037 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 3.56e-06 | 163 | 102 | 7 | M2769 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | PLK5 SRCIN1 FOXD4L6 DNAJC6 FOXD4L5 PRDM8 FOXD4L4 CELSR1 FOXD4L3 SLC18A2 BSN PCDH8 | 3.91e-06 | 601 | 102 | 12 | MM866 |
| Coexpression | PILON_KLF1_TARGETS_UP | COL2A1 COL3A1 COL4A1 COL11A1 C2orf72 SUGP2 AMOTL1 CPEB4 TMEM30A COL1A1 COL1A2 | 4.31e-06 | 503 | 102 | 11 | M2226 |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 5.14e-06 | 64 | 102 | 5 | M2572 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 6.94e-06 | 68 | 102 | 5 | M1373 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.46e-06 | 69 | 102 | 5 | M10165 | |
| Coexpression | PILON_KLF1_TARGETS_UP | COL2A1 COL3A1 COL4A1 COL11A1 C2orf72 SUGP2 AMOTL1 CPEB4 TMEM30A COL1A1 COL1A2 | 8.57e-06 | 541 | 102 | 11 | MM1061 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 9.20e-06 | 72 | 102 | 5 | MM1131 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 9.23e-06 | 11 | 102 | 3 | M47997 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.01e-05 | 126 | 102 | 6 | M39132 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.03e-05 | 35 | 102 | 4 | MM17054 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.05e-05 | 74 | 102 | 5 | M4479 | |
| Coexpression | KRAS.DF.V1_DN | 1.08e-05 | 193 | 102 | 7 | M2861 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.11e-05 | 194 | 102 | 7 | M39122 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.45e-05 | 79 | 102 | 5 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.54e-05 | 80 | 102 | 5 | MM1285 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 1.77e-05 | 40 | 102 | 4 | M1574 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.77e-05 | 40 | 102 | 4 | M5887 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.19e-05 | 86 | 102 | 5 | M2259 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 2.49e-05 | 303 | 102 | 8 | M39040 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.52e-05 | 15 | 102 | 3 | MM402 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 2.60e-05 | 44 | 102 | 4 | M18274 | |
| Coexpression | DEMAGALHAES_AGING_DN | 3.09e-05 | 16 | 102 | 3 | M2145 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 3.11e-05 | 46 | 102 | 4 | MM670 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 3.11e-05 | 46 | 102 | 4 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 3.39e-05 | 47 | 102 | 4 | M1399 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 4.99e-05 | 102 | 102 | 5 | MM1064 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 5.30e-05 | 19 | 102 | 3 | M15125 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 5.39e-05 | 338 | 102 | 8 | M17094 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A1 DOK1 COL4A5 COL5A1 COL11A2 COL19A1 CYP27A1 SRCIN1 COL22A1 NR2F1 AASS FGF2 PLK1 ESPL1 | 5.84e-05 | 1054 | 102 | 14 | M45798 |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN | 6.80e-05 | 56 | 102 | 4 | M19590 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | COL4A1 COL4A2 COL5A1 ADGRB2 BCL9 MAP3K12 PRDM8 SH3PXD2A AASS PAWR | 7.01e-05 | 563 | 102 | 10 | M15103 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | DOK1 COL5A1 COL19A1 PLK5 ADGRB2 HLX TBX18 PRDM8 NKD2 SH3PXD2A DMRTA2 PAWR PCDH8 VAV2 | 7.14e-05 | 1074 | 102 | 14 | M1941 |
| Coexpression | CROMER_TUMORIGENESIS_UP | 7.80e-05 | 58 | 102 | 4 | M178 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 7.89e-05 | 357 | 102 | 8 | MM828 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 8.35e-05 | 22 | 102 | 3 | M40074 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 8.52e-05 | 267 | 102 | 7 | M6100 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 9.51e-05 | 61 | 102 | 4 | M8510 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | COL11A1 SRCIN1 DNAJC6 FOXD4L5 PRDM8 MAST4 SUGP2 SH3PXD2A CPEB4 OGDHL BSN PCDH8 PRRT4 VAV2 | 9.74e-05 | 1106 | 102 | 14 | M39071 |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.01e-04 | 62 | 102 | 4 | M16774 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.08e-04 | 120 | 102 | 5 | M42505 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 1.20e-04 | 282 | 102 | 7 | MM822 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.22e-04 | 65 | 102 | 4 | M39309 | |
| Coexpression | RAMASWAMY_METASTASIS_UP | 1.29e-04 | 66 | 102 | 4 | M6698 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A1 COL4A2 COL4A6 COL5A1 ZBTB47 ARMCX4 SLC18A2 SH3PXD2A COL1A2 | 1.34e-04 | 493 | 102 | 9 | M19391 |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN | 1.34e-04 | 200 | 102 | 6 | M5816 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP | 1.34e-04 | 200 | 102 | 6 | M9324 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 1.51e-04 | 501 | 102 | 9 | M5389 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 AMOTL1 COL1A1 COL1A2 | 1.60e-04 | 505 | 102 | 9 | M39167 |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 1.80e-04 | 211 | 102 | 6 | M12225 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.81e-04 | 72 | 102 | 4 | M9908 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 1.94e-04 | 305 | 102 | 7 | M19875 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 1.94e-04 | 29 | 102 | 3 | M7581 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 NR2F1 TBX18 COL21A1 CNTFR COL1A1 COL1A2 | 1.99e-04 | 767 | 102 | 11 | M39209 |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.13e-04 | 75 | 102 | 4 | MM1084 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 2.24e-04 | 76 | 102 | 4 | M11825 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.30e-04 | 141 | 102 | 5 | M10381 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.53e-04 | 144 | 102 | 5 | M5942 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 2.70e-04 | 146 | 102 | 5 | MM973 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.87e-04 | 33 | 102 | 3 | M9167 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 3.14e-04 | 83 | 102 | 4 | M2448 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 3.20e-04 | 235 | 102 | 6 | M5311 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.42e-04 | 35 | 102 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.72e-04 | 36 | 102 | 3 | MM1212 | |
| Coexpression | HALLMARK_HEDGEHOG_SIGNALING | 3.72e-04 | 36 | 102 | 3 | M5919 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL2A1 COL4A5 COL4A6 ADGRB2 HLX COL24A1 FOXD4L4 CNTNAP5 MAST4 FOXD4L3 PCDH8 CNTFR AGAP2 | 3.89e-04 | 1115 | 102 | 13 | M10371 |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 4.27e-04 | 90 | 102 | 4 | M38984 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 4.46e-04 | 91 | 102 | 4 | M40180 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 4.60e-04 | 352 | 102 | 7 | M17471 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_UP | COL5A1 ESS2 PLK5 ZBTB47 PPP1R26 TTLL4 DMRTA2 PCDH8 VAV2 AGAP2 COL1A1 | 5.00e-04 | 855 | 102 | 11 | M2098 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 5.48e-04 | 41 | 102 | 3 | M47988 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 6.13e-04 | 99 | 102 | 4 | M40255 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 6.13e-04 | 99 | 102 | 4 | M39152 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 6.41e-04 | 268 | 102 | 6 | M45796 | |
| Coexpression | BCAT_GDS748_DN | 7.21e-04 | 45 | 102 | 3 | M2677 | |
| Coexpression | JONES_OVARY_THECA | 7.69e-04 | 46 | 102 | 3 | M48349 | |
| Coexpression | KRASNOSELSKAYA_ILF3_TARGETS_DN | 7.69e-04 | 46 | 102 | 3 | M12166 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_UP | 7.92e-04 | 106 | 102 | 4 | MM595 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 8.71e-04 | 48 | 102 | 3 | M1246 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 8.71e-04 | 48 | 102 | 3 | M10253 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 5.00e-07 | 66 | 95 | 6 | BM Top 100 - endometrium | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | COL2A1 COL3A1 FLYWCH1 CYP27A1 HLX NR2F1 PRR12 NKD2 GLI1 TTLL4 ZNF516 MAPK7 DMWD PLK1 ESPL1 CCDC86 PRRC2A CNTFR CBX2 | 8.77e-06 | 1371 | 95 | 19 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 1.78e-05 | 72 | 95 | 5 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 2.03e-05 | 74 | 95 | 5 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | BCL9L COL5A1 COL11A1 ADGRB2 BCL9 NCKAP5L DNAJC6 NR2F1 PPP1R26 EPS15L1 NKD2 SH3PXD2A GLI1 FGF2 PRRC2A CNTFR COL1A2 | 2.31e-05 | 1208 | 95 | 17 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000 | COL2A1 ESS2 FLYWCH1 CYP27A1 AKNA COL22A1 BCL9 NR2F1 TBX18 COL24A1 RBM14 DMRTA2 PCDH8 CBX2 | 2.45e-05 | 850 | 95 | 14 | gudmap_developingKidney_e11.5_metaneph mesench_1000 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | COL2A1 FLYWCH1 NR2F1 PRR12 NKD2 GLI1 TTLL4 ZNF516 MAPK7 DMWD PLK1 ESPL1 CCDC86 PRRC2A CNTFR CBX2 | 3.67e-05 | 1125 | 95 | 16 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | cervix, uterine | 5.61e-05 | 149 | 95 | 6 | cervix, uterine | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | COL2A1 COL3A1 COL11A1 NR2F1 C2orf72 COL21A1 PCDH8 PRRT4 COL1A1 COL1A2 | 7.56e-05 | 496 | 95 | 10 | PCBC_EB_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | COL2A1 COL3A1 COL11A1 NR2F1 C2orf72 COL21A1 PCDH8 PRRT4 COL1A1 COL1A2 | 7.69e-05 | 497 | 95 | 10 | PCBC_EB_fibroblast_500 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 COL11A2 NR2F1 C2orf72 PCDH8 PRRT4 CNTFR COL1A1 COL1A2 | 8.26e-05 | 951 | 95 | 14 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 NR2F1 C2orf72 TBX18 NKD2 PCDH8 PRRT4 CNTFR COL1A1 COL1A2 | 9.96e-05 | 1094 | 95 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL11A1 COL11A2 NR2F1 C2orf72 COL21A1 BSN PCDH8 PRRT4 CNTFR COL1A1 COL1A2 | 1.21e-04 | 986 | 95 | 14 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL11A1 COL11A2 NR2F1 C2orf72 COL24A1 NKD2 COL21A1 PCDH8 PRRT4 CNTFR COL1A1 COL1A2 | 1.29e-04 | 992 | 95 | 14 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.33e-04 | 336 | 95 | 8 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.61e-04 | 114 | 95 | 5 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k5 | |
| CoexpressionAtlas | BM Top 100 - cervix | 2.19e-04 | 66 | 95 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.59e-04 | 197 | 95 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 2.60e-04 | 69 | 95 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 2.75e-04 | 70 | 95 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 3.23e-04 | 73 | 95 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 3.40e-04 | 74 | 95 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - vagina | 3.77e-04 | 76 | 95 | 4 | BM Top 100 - vagina | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.78e-04 | 137 | 95 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL11A1 NR2F1 C2orf72 TTBK1 NKD2 COL21A1 PCDH8 PRRT4 CNTFR COL1A1 COL1A2 | 4.75e-04 | 994 | 95 | 13 | PCBC_EB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL11A1 HLX NR2F1 C2orf72 TBX18 PRDM8 PRRT4 CNTFR COL1A1 COL1A2 | 4.75e-04 | 994 | 95 | 13 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 COL3A1 BCL9 COL24A1 NKD2 SLC18A2 SH3PXD2A SLTM FGF2 COL1A1 COL1A2 | 4.88e-04 | 744 | 95 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL11A1 ARHGAP40 CYP27A1 MBD6 DNAJC6 CELSR1 AMOTL1 ZNF516 | 5.95e-04 | 1153 | 95 | 14 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.45e-04 | 234 | 95 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_500 | 7.03e-04 | 431 | 95 | 8 | gudmap_developingKidney_e11.5_metaneph mesench_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.18e-04 | 331 | 95 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.25e-04 | 433 | 95 | 8 | Arv_EB-LF_1000_K4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | COL3A1 COL4A1 COL4A2 COL5A1 HLX TBX18 NKD2 COL21A1 GLI1 COL1A1 COL1A2 | 1.27e-12 | 200 | 102 | 11 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | COL3A1 COL4A1 COL4A2 COL5A1 HLX TBX18 NKD2 COL21A1 GLI1 COL1A1 COL1A2 | 1.27e-12 | 200 | 102 | 11 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 NR2F1 NKD2 CNTFR COL1A1 COL1A2 | 1.34e-11 | 181 | 102 | 10 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 NR2F1 NKD2 CNTFR COL1A1 COL1A2 | 1.34e-11 | 181 | 102 | 10 | c62b0a2422377ffadaab63edd538e87a06fa5017 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 COL3A1 COL5A1 COL11A1 COL11A2 C2orf72 COL24A1 FGF2 COL1A1 COL1A2 | 1.95e-11 | 188 | 102 | 10 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 NR2F1 SH3PXD2A PAWR COL1A1 COL1A2 | 2.80e-11 | 195 | 102 | 10 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 2.80e-11 | 195 | 102 | 10 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | COL3A1 COL4A1 COL4A2 COL5A1 NR2F1 NKD2 AASS FGF2 COL1A1 COL1A2 | 2.94e-11 | 196 | 102 | 10 | af206bb5bbb8b604a6212acd79878bcc3d326cec |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 NR2F1 TBX18 SH3PXD2A PAWR COL1A1 COL1A2 | 2.94e-11 | 196 | 102 | 10 | cb61757646653f89faba503cb5d99e5dd5197b4c |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL5A1 NR2F1 TBX18 SH3PXD2A PAWR COL1A1 COL1A2 | 2.94e-11 | 196 | 102 | 10 | 44e2df1b61e3819eae7e482bef0a733afe852d67 |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | COL3A1 COL4A1 COL4A2 COL5A1 NR2F1 NKD2 AASS FGF2 COL1A1 COL1A2 | 3.09e-11 | 197 | 102 | 10 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 3.25e-11 | 198 | 102 | 10 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 NR2F1 COL21A1 SH3PXD2A COL1A1 COL1A2 | 3.42e-11 | 199 | 102 | 10 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 COL11A2 NR2F1 FGF2 COL1A2 | 3.59e-11 | 200 | 102 | 10 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | COL3A1 COL5A1 COL11A1 COL22A1 ADAM8 COL24A1 NKD2 COL1A1 COL1A2 | 4.14e-10 | 183 | 102 | 9 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | COL3A1 COL4A5 COL4A6 COL5A1 TBX18 NKD2 COL21A1 COL1A1 COL1A2 | 5.50e-10 | 189 | 102 | 9 | 4f9608b84d135268a17455661870c46ae8554a24 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.62e-10 | 193 | 102 | 9 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 COL11A2 COL1A1 COL1A2 | 6.93e-10 | 194 | 102 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 7.25e-10 | 195 | 102 | 9 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 7.94e-10 | 197 | 102 | 9 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 COL4A5 COL5A1 COL11A1 CNTFR COL1A1 COL1A2 | 7.94e-10 | 197 | 102 | 9 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL3A1 COL5A1 COL11A1 COL11A2 COL22A1 CNTFR COL1A1 COL1A2 | 8.30e-10 | 198 | 102 | 9 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL11A1 NR2F1 TBX18 COL24A1 COL21A1 GLI1 COL1A1 COL1A2 | 8.30e-10 | 198 | 102 | 9 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | COL3A1 COL4A1 COL4A2 COL5A1 COL11A1 NR2F1 TBX18 COL1A1 COL1A2 | 8.68e-10 | 199 | 102 | 9 | 12133087eae9f0e9b6c13a71e8187117768e64ce |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL3A1 COL4A1 COL4A2 COL5A1 NR2F1 COL21A1 FGF2 COL1A1 COL1A2 | 9.07e-10 | 200 | 102 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.07e-10 | 200 | 102 | 9 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-09 | 153 | 102 | 8 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-09 | 153 | 102 | 8 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-09 | 153 | 102 | 8 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.05e-09 | 157 | 102 | 8 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.21e-09 | 158 | 102 | 8 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 4.30e-09 | 164 | 102 | 8 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-09 | 169 | 102 | 8 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.55e-09 | 173 | 102 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-09 | 177 | 102 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-09 | 177 | 102 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.94e-09 | 180 | 102 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.94e-09 | 180 | 102 | 8 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.94e-09 | 180 | 102 | 8 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.94e-09 | 180 | 102 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.15e-08 | 186 | 102 | 8 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-08 | 187 | 102 | 8 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-08 | 187 | 102 | 8 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-08 | 188 | 102 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-08 | 188 | 102 | 8 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.26e-08 | 188 | 102 | 8 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-08 | 188 | 102 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.31e-08 | 189 | 102 | 8 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.36e-08 | 190 | 102 | 8 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-08 | 191 | 102 | 8 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-08 | 191 | 102 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-08 | 193 | 102 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.54e-08 | 193 | 102 | 8 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-08 | 193 | 102 | 8 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.60e-08 | 194 | 102 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-08 | 194 | 102 | 8 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-08 | 194 | 102 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-08 | 194 | 102 | 8 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.60e-08 | 194 | 102 | 8 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.60e-08 | 194 | 102 | 8 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.67e-08 | 195 | 102 | 8 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-08 | 195 | 102 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.67e-08 | 195 | 102 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-08 | 195 | 102 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 196 | 102 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 196 | 102 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-08 | 196 | 102 | 8 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.74e-08 | 196 | 102 | 8 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-08 | 196 | 102 | 8 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.74e-08 | 196 | 102 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-08 | 196 | 102 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-08 | 196 | 102 | 8 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.81e-08 | 197 | 102 | 8 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-08 | 197 | 102 | 8 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-08 | 197 | 102 | 8 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-08 | 197 | 102 | 8 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.81e-08 | 197 | 102 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-08 | 198 | 102 | 8 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-08 | 198 | 102 | 8 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-08 | 198 | 102 | 8 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 198 | 102 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-08 | 198 | 102 | 8 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.88e-08 | 198 | 102 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-08 | 198 | 102 | 8 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 1.88e-08 | 198 | 102 | 8 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-08 | 198 | 102 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-08 | 198 | 102 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-08 | 199 | 102 | 8 | 01ab0363558f215f9979e20fd5170d8fee149cea | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-08 | 199 | 102 | 8 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-08 | 199 | 102 | 8 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.95e-08 | 199 | 102 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-08 | 199 | 102 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 199 | 102 | 8 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-08 | 199 | 102 | 8 | 08bdcabc3fce787578a8eb66fc8412b0974fa6cc | |
| ToppCell | distal-mesenchymal-Myofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.95e-08 | 199 | 102 | 8 | 79917b5225cb45b4a0ea937f79f1752346e4346e | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-08 | 199 | 102 | 8 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.95e-08 | 199 | 102 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.95e-08 | 199 | 102 | 8 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-08 | 199 | 102 | 8 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.03e-08 | 200 | 102 | 8 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.19e-06 | 50 | 57 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.19e-06 | 50 | 57 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of CDH11 | 8.27e-06 | 25 | 57 | 4 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 3.69e-05 | 36 | 57 | 4 | GNF2_PTX3 | |
| Computational | Adhesion molecules. | 9.59e-05 | 141 | 57 | 6 | MODULE_122 | |
| Drug | BAPN | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 TSC1 COL22A1 COL24A1 COL21A1 AASS COL1A1 COL1A2 | 1.44e-23 | 71 | 100 | 16 | CID000001647 |
| Drug | GK-101 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 2.14e-22 | 36 | 100 | 13 | CID000161853 |
| Drug | halofuginone lactate | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 FGF2 PAWR COL1A1 COL1A2 | 3.36e-22 | 85 | 100 | 16 | CID000062891 |
| Drug | Madecassol | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 9.10e-21 | 46 | 100 | 13 | CID000108062 |
| Drug | AC1LAKND | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 9.44e-21 | 62 | 100 | 14 | CID000470146 |
| Drug | d-indobufen | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 3.13e-20 | 50 | 100 | 13 | CID000044562 |
| Drug | ridogrel | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 5.56e-20 | 52 | 100 | 13 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 7.34e-20 | 53 | 100 | 13 | CID000023340 |
| Drug | strontium ranelate | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 CYP27A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 2.58e-19 | 77 | 100 | 14 | CID006918182 |
| Drug | AC1L1C2F | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 FGF2 AGAP2 COL1A1 COL1A2 | 1.22e-18 | 110 | 100 | 15 | CID000001711 |
| Drug | Tranilast sodium | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 2.45e-18 | 115 | 100 | 15 | CID000005527 |
| Drug | 4-hydroxyproline | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 3.13e-18 | 91 | 100 | 14 | CID000000825 |
| Drug | malotilate | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 4.75e-18 | 71 | 100 | 13 | CID000004006 |
| Drug | Selara | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 FGF2 MAPK7 COL1A1 COL1A2 | 8.95e-18 | 125 | 100 | 15 | CID000150310 |
| Drug | AC1NMZ1B | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.02e-17 | 75 | 100 | 13 | CID005034185 |
| Drug | ticlopidine | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.93e-17 | 103 | 100 | 14 | CID000005472 |
| Drug | hydroxylysine | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 4.40e-17 | 109 | 100 | 14 | CID000001029 |
| Drug | PCR 4099 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 PAWR COL1A1 COL1A2 | 4.59e-17 | 139 | 100 | 15 | CID000002806 |
| Drug | PPACK | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 PAWR COL1A1 COL1A2 | 7.43e-17 | 113 | 100 | 14 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 8.44e-17 | 114 | 100 | 14 | CID000439300 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 PLK1 VAV2 COL1A1 COL1A2 | 4.72e-16 | 162 | 100 | 15 | CID000072363 |
| Drug | khellin | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 1.07e-15 | 171 | 100 | 15 | CID000003828 |
| Drug | pirfenidone | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.31e-15 | 138 | 100 | 14 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 1.45e-15 | 139 | 100 | 14 | CID000004727 |
| Drug | AC1L1DD6 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 2.12e-15 | 179 | 100 | 15 | CID000002299 |
| Drug | candesartan cilexetil | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 2.64e-15 | 145 | 100 | 14 | CID000002540 |
| Drug | AC1Q6PCP | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 NR2F1 COL24A1 COL21A1 SLC14A2 COL1A1 COL1A2 | 4.42e-15 | 230 | 100 | 16 | CID000005267 |
| Drug | BPAT-143 | 6.17e-15 | 6 | 100 | 6 | CID000146249 | |
| Drug | DMSe | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 2.12e-14 | 132 | 100 | 13 | CID000020796 |
| Drug | colchine | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 ESS2 COL19A1 COL22A1 COL24A1 COL21A1 FGF2 BSN PLK1 COL1A1 COL1A2 | 6.82e-14 | 383 | 100 | 18 | CID000002833 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 1.08e-13 | 189 | 100 | 14 | CID000001413 |
| Drug | foscarnet | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 BSN COL1A1 COL1A2 | 1.16e-13 | 190 | 100 | 14 | CID000003414 |
| Drug | hyaluronan | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 6.16e-13 | 263 | 100 | 15 | CID000024759 |
| Drug | isodesmosine | 1.32e-12 | 33 | 100 | 8 | CID000013811 | |
| Drug | 351A | 1.88e-12 | 20 | 100 | 7 | CID000122144 | |
| Drug | silibinin | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 1.96e-12 | 285 | 100 | 15 | CID000005213 |
| Drug | AC1L18QD | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 1.28e-11 | 325 | 100 | 15 | CID000000213 |
| Drug | NC-4 | 1.62e-11 | 44 | 100 | 8 | CID006420119 | |
| Drug | AC1L1KMJ | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 EPS15L1 COL21A1 PAWR MAPK7 COL1A1 COL1A2 | 2.83e-11 | 476 | 100 | 17 | CID000030956 |
| Drug | L-3,4-dehydroproline | COL2A1 COL3A1 COL5A1 COL11A1 COL19A1 COL22A1 COL21A1 COL1A1 COL1A2 | 3.24e-11 | 73 | 100 | 9 | CID000094284 |
| Drug | prostacyclin sodium salt | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 COL1A1 COL1A2 | 7.53e-11 | 250 | 100 | 13 | CID000000159 |
| Drug | desmosine | 7.84e-11 | 53 | 100 | 8 | CID000025435 | |
| Drug | Y-27632 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 PAWR MAPK7 VAV2 COL1A1 COL1A2 | 1.01e-10 | 444 | 100 | 16 | CID000005711 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 1.03e-10 | 314 | 100 | 14 | CID000447989 |
| Drug | losartan | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 1.07e-10 | 378 | 100 | 15 | CID000003961 |
| Drug | Collagenase | 3.50e-10 | 4 | 100 | 4 | DB00048 | |
| Drug | chondroitin sulfate | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 FGF2 COL1A1 COL1A2 | 3.66e-10 | 413 | 100 | 15 | CID000024766 |
| Drug | pyridinoline | COL2A1 COL3A1 COL5A1 COL11A1 COL11A2 CYP27A1 COL21A1 COL1A1 COL1A2 | 5.26e-10 | 99 | 100 | 9 | CID000105068 |
| Drug | PD123177 | 7.21e-10 | 43 | 100 | 7 | CID000114899 | |
| Drug | trapidil | 5.63e-09 | 57 | 100 | 7 | CID000005531 | |
| Drug | Sirius red | 9.03e-09 | 35 | 100 | 6 | CID005486818 | |
| Drug | 4-aminoazobenzene | 1.61e-08 | 66 | 100 | 7 | CID000006051 | |
| Drug | AC1MRIIV | 1.79e-08 | 39 | 100 | 6 | CID003518584 | |
| Drug | aspirin | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 COL22A1 COL24A1 COL21A1 MAPK7 COL1A1 COL1A2 | 2.40e-08 | 563 | 100 | 15 | CID000002244 |
| Drug | LS-63783 | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL19A1 CYP27A1 COL22A1 COL24A1 COL21A1 MAPK7 PCDH8 COL1A1 COL1A2 | 7.46e-08 | 804 | 100 | 17 | CID000000231 |
| Drug | 1h00 | 1.68e-07 | 56 | 100 | 6 | CID000445950 | |
| Drug | D3273 | 1.91e-07 | 94 | 100 | 7 | CID005464587 | |
| Drug | LMWH | COL2A1 COL3A1 COL4A1 COL4A5 COL4A6 COL5A1 COL11A1 COL11A2 COL22A1 COL24A1 COL21A1 FGF2 PAWR COL1A1 COL1A2 | 2.01e-07 | 663 | 100 | 15 | CID000000772 |
| Drug | AC1Q641C | 3.11e-07 | 62 | 100 | 6 | CID000005005 | |
| Drug | ascorbate-2-phosphate | 4.61e-07 | 15 | 100 | 4 | ctd:C011669 | |
| Drug | dermatan sulfate | COL2A1 COL3A1 COL4A5 COL5A1 COL11A1 COL11A2 COL21A1 FGF2 COL1A1 | 5.54e-07 | 220 | 100 | 9 | CID000032756 |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 1.63e-06 | 6 | 100 | 3 | ctd:C502971 | |
| Drug | AG-H-50319 | 1.63e-06 | 6 | 100 | 3 | CID011819195 | |
| Drug | homocystine | 1.65e-06 | 82 | 100 | 6 | CID000010010 | |
| Drug | pyrachlostrobin | COL4A1 DOK1 COL4A5 COL4A6 COL5A1 COL11A1 COL19A1 COL22A1 CELSR1 AASS AMOTL1 ZNF516 DMRTA2 PAWR COL1A1 | 2.51e-06 | 811 | 100 | 15 | ctd:C513428 |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A | 2.67e-06 | 198 | 100 | 8 | 2570_DN | |
| Drug | AC1L9HPX | 3.24e-06 | 92 | 100 | 6 | CID000445279 | |
| Drug | angiotensin | COL2A1 COL3A1 COL4A5 COL5A1 COL11A2 COL21A1 FGF2 MAPK7 COL1A1 | 4.29e-06 | 282 | 100 | 9 | CID003083715 |
| Drug | Cu-GHK | 1.91e-05 | 2 | 100 | 2 | CID000378611 | |
| Drug | 5'-methylthioadenosine | 1.91e-05 | 2 | 100 | 2 | ctd:C008500 | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.48e-05 | 195 | 100 | 7 | 4063_UP | |
| Drug | TC-6 | 2.56e-05 | 39 | 100 | 4 | CID000398799 | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 7470_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 7248_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 5988_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.83e-05 | 199 | 100 | 7 | 3200_UP | |
| Drug | fluoride | 3.15e-05 | 278 | 100 | 8 | CID000014917 | |
| Drug | 1zd2 | 4.55e-05 | 45 | 100 | 4 | CID004149241 | |
| Drug | calcium phosphate | 5.10e-05 | 149 | 100 | 6 | CID000024441 | |
| Drug | AC1NRBJE | 5.70e-05 | 152 | 100 | 6 | CID005288446 | |
| Drug | MDL 27044 | 5.71e-05 | 3 | 100 | 2 | CID000125537 | |
| Drug | aldosterone | COL2A1 COL3A1 COL5A1 COL11A1 COL11A2 COL21A1 MAPK7 SLC14A2 COL1A1 | 6.40e-05 | 397 | 100 | 9 | CID000005839 |
| Drug | deoxypyridinoline | 7.26e-05 | 98 | 100 | 5 | CID000105071 | |
| Drug | Coal Ash | 7.32e-05 | 159 | 100 | 6 | ctd:D060729 | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 8.07e-05 | 52 | 100 | 4 | ctd:C573693 | |
| Drug | GSK1210151A | 8.07e-05 | 52 | 100 | 4 | ctd:C568713 | |
| Drug | fullerene C60 | COL2A1 COL4A2 COL5A1 ESS2 CYP27A1 PLK5 AKNA ZBTB47 SRCIN1 MBD6 ADAM8 SH3PXD2A RBM14 FGF2 OGDHL DMRTA2 BSN PRRC2A | 8.39e-05 | 1498 | 100 | 18 | ctd:C069837 |
| Drug | galactosylhydroxylysine | 8.88e-05 | 20 | 100 | 3 | CID000123986 | |
| Drug | Rgd Peptide | 8.99e-05 | 239 | 100 | 7 | CID000104802 | |
| Drug | glycyl-L-leucine | 9.36e-05 | 54 | 100 | 4 | CID000092843 | |
| Drug | AC1L1TXN | 9.36e-05 | 54 | 100 | 4 | CID000060791 | |
| Drug | mitomycin C | 9.47e-05 | 241 | 100 | 7 | CID000005746 | |
| Drug | diacetylrhein | 1.14e-04 | 4 | 100 | 2 | ctd:C025292 | |
| Drug | Glucose | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 ESS2 MAFA TSC1 ADAM8 NR2F1 GLI1 RBM14 FGF2 PAWR PLK1 COL1A1 COL1A2 | 1.42e-04 | 1420 | 100 | 17 | ctd:D005947 |
| Drug | Frie Mao 1-43 | 1.51e-04 | 61 | 100 | 4 | CID002733618 | |
| Drug | ABT-100 | 1.56e-04 | 24 | 100 | 3 | CID006451154 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 187 | 100 | 6 | 5438_UP | |
| Drug | EU m | 1.89e-04 | 5 | 100 | 2 | CID000205309 | |
| Drug | Saralasin | 1.89e-04 | 5 | 100 | 2 | ctd:D012504 | |
| Drug | relacatib | 1.89e-04 | 5 | 100 | 2 | CID006918602 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.91e-10 | 53 | 95 | 7 | C4707243 | |
| Disease | Stickler syndrome | 3.22e-07 | 5 | 95 | 3 | cv:C0265253 | |
| Disease | Ehlers-Danlos Syndrome | 3.22e-07 | 5 | 95 | 3 | C0013720 | |
| Disease | Nephrotic Syndrome | 1.67e-06 | 27 | 95 | 4 | C0027726 | |
| Disease | Ehlers-Danlos syndrome | 1.79e-06 | 8 | 95 | 3 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.68e-06 | 9 | 95 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Nephrosclerosis | 5.24e-06 | 11 | 95 | 3 | C0027719 | |
| Disease | collagen disease (implicated_via_orthology) | 6.96e-06 | 12 | 95 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 1.03e-05 | 2 | 95 | 2 | C1839884 | |
| Disease | Fibrochondrogenesis | 1.03e-05 | 2 | 95 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 1.03e-05 | 2 | 95 | 2 | C4082301 | |
| Disease | Congenital porencephaly | 1.03e-05 | 2 | 95 | 2 | C0302892 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 1.03e-05 | 2 | 95 | 2 | C0268345 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 1.03e-05 | 2 | 95 | 2 | C4520892 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 1.03e-05 | 2 | 95 | 2 | C4551623 | |
| Disease | PORENCEPHALY, FAMILIAL | 1.03e-05 | 2 | 95 | 2 | C1867983 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 1.03e-05 | 2 | 95 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 1.03e-05 | 2 | 95 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 1.03e-05 | 2 | 95 | 2 | cv:C0268362 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 1.03e-05 | 2 | 95 | 2 | cv:C0268358 | |
| Disease | Stickler syndrome, type 3 | 1.03e-05 | 2 | 95 | 2 | C1861481 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 1.03e-05 | 2 | 95 | 2 | 259420 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | Post-traumatic Porencephaly | 1.03e-05 | 2 | 95 | 2 | C3698507 | |
| Disease | Megaepiphyseal dwarfism | 1.03e-05 | 2 | 95 | 2 | C1855310 | |
| Disease | Porencephaly | 1.03e-05 | 2 | 95 | 2 | C4082173 | |
| Disease | Parkinson's disease 19A (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0060891 (implicated_via_orthology) | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.03e-05 | 2 | 95 | 2 | C3281105 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | Leiomyoma, Epithelioid | 1.03e-05 | 2 | 95 | 2 | C0086533 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 1.03e-05 | 2 | 95 | 2 | 166220 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 1.03e-05 | 2 | 95 | 2 | 166210 | |
| Disease | Liver Cirrhosis | 2.12e-05 | 103 | 95 | 5 | C0023890 | |
| Disease | Fibrosis, Liver | 2.33e-05 | 105 | 95 | 5 | C0239946 | |
| Disease | Oral Submucous Fibrosis | 2.55e-05 | 18 | 95 | 3 | C0029172 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 3.07e-05 | 3 | 95 | 2 | C4552122 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 3.07e-05 | 3 | 95 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 3.07e-05 | 3 | 95 | 2 | C0220679 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 3.07e-05 | 3 | 95 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 3.07e-05 | 3 | 95 | 2 | 614519 | |
| Disease | OSTEOPOROSIS | 6.13e-05 | 4 | 95 | 2 | 166710 | |
| Disease | Ischemic stroke | 8.72e-05 | 324 | 95 | 7 | HP_0002140 | |
| Disease | cortical surface area measurement | COL2A1 COL11A1 ZAN COL22A1 MBD6 NR2F1 COL24A1 CELSR1 MAST4 C6orf15 CPEB4 DMRTA2 PAWR PRRC2A | 1.01e-04 | 1345 | 95 | 14 | EFO_0010736 |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 1.02e-04 | 5 | 95 | 2 | C0268358 | |
| Disease | Stickler syndrome, type 1 | 1.02e-04 | 5 | 95 | 2 | C2020284 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 1.02e-04 | 5 | 95 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 1.02e-04 | 5 | 95 | 2 | C0023931 | |
| Disease | Disproportionate short stature | 1.14e-04 | 77 | 95 | 4 | C0878659 | |
| Disease | Cleft Palate | 1.39e-04 | 81 | 95 | 4 | C0008925 | |
| Disease | Osteoporosis | 1.53e-04 | 6 | 95 | 2 | cv:C0029456 | |
| Disease | Cartilage Diseases | 1.53e-04 | 6 | 95 | 2 | C0007302 | |
| Disease | Chondromalacia | 1.53e-04 | 6 | 95 | 2 | C0085700 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Keloid | 1.96e-04 | 35 | 95 | 3 | C0022548 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 2.13e-04 | 7 | 95 | 2 | C1846545 | |
| Disease | Bleeding tendency | 2.13e-04 | 7 | 95 | 2 | C1458140 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 3.64e-04 | 9 | 95 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Hematuria | 3.64e-04 | 9 | 95 | 2 | C0018965 | |
| Disease | Early Pregnancy Loss | 4.33e-04 | 109 | 95 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 4.33e-04 | 109 | 95 | 4 | C0000786 | |
| Disease | Miscarriage | 4.33e-04 | 109 | 95 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 4.33e-04 | 109 | 95 | 4 | C0000822 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 4.54e-04 | 10 | 95 | 2 | C0268363 | |
| Disease | myopathy (implicated_via_orthology) | 5.03e-04 | 48 | 95 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Osteogenesis imperfecta type III (disorder) | 5.54e-04 | 11 | 95 | 2 | C0268362 | |
| Disease | Aortic Valve Insufficiency | 5.54e-04 | 11 | 95 | 2 | C0003504 | |
| Disease | Sensory hearing loss | 5.54e-04 | 11 | 95 | 2 | C1691779 | |
| Disease | Fibrosis | 5.68e-04 | 50 | 95 | 3 | C0016059 | |
| Disease | Cirrhosis | 5.68e-04 | 50 | 95 | 3 | C1623038 | |
| Disease | Disorder of eye | 6.26e-04 | 212 | 95 | 5 | C0015397 | |
| Disease | cleft palate (is_implicated_in) | 6.63e-04 | 12 | 95 | 2 | DOID:674 (is_implicated_in) | |
| Disease | intracranial aneurysm (is_implicated_in) | 6.63e-04 | 12 | 95 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 7.82e-04 | 13 | 95 | 2 | C0029434 | |
| Disease | psychosis | 9.10e-04 | 14 | 95 | 2 | EFO_0005407 | |
| Disease | osteoarthritis (implicated_via_orthology) | 1.05e-03 | 15 | 95 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Cerebrovascular accident | 1.07e-03 | 62 | 95 | 3 | C0038454 | |
| Disease | hypertension, white matter hyperintensity measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | Cocaine Dependence | 1.08e-03 | 139 | 95 | 4 | C0600427 | |
| Disease | arterial stiffness measurement | 1.17e-03 | 64 | 95 | 3 | EFO_0004517 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.20e-03 | 16 | 95 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.20e-03 | 16 | 95 | 2 | C3541456 | |
| Disease | Blood Coagulation Disorders | 1.20e-03 | 16 | 95 | 2 | C0005779 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.20e-03 | 16 | 95 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.20e-03 | 16 | 95 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.20e-03 | 16 | 95 | 2 | C0025237 | |
| Disease | Hereditary hearing loss and deafness | 1.29e-03 | 146 | 95 | 4 | cv:C0236038 | |
| Disease | intraocular pressure measurement | 1.31e-03 | 509 | 95 | 7 | EFO_0004695 | |
| Disease | Van Buchem disease | 1.35e-03 | 17 | 95 | 2 | C0432272 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.35e-03 | 17 | 95 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.35e-03 | 17 | 95 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.35e-03 | 17 | 95 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.35e-03 | 17 | 95 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.35e-03 | 17 | 95 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.35e-03 | 17 | 95 | 2 | C0751781 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.52e-03 | 18 | 95 | 2 | C0751779 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.69e-03 | 19 | 95 | 2 | DOID:2256 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGKPATSGAAGSPGR | 771 | O60241 | |
| PPSGPFTSSLGGAGF | 751 | Q9UBC2 | |
| PGLPGSKGATGDIFG | 741 | Q14031 | |
| KSGLPGAPGFPGISG | 826 | Q14031 | |
| SKPPPAGETVTGGFG | 196 | Q9H6F5 | |
| VFPPEPGAAKPGGAA | 56 | A6NCS6 | |
| PGKFSPAGVEGCPAL | 331 | Q9UDR5 | |
| AGEPGFKGSRGDPGP | 961 | P08572 | |
| LPGTKGFPGSPGSDI | 1201 | P08572 | |
| ISGAPGDKGAPGIFG | 1276 | P08572 | |
| IFTKSTGGPPGSGPL | 351 | Q99490 | |
| KGFKVGGGPSPAQPA | 286 | Q8IY63 | |
| FLGGGSAGPKNPAPT | 611 | Q9NYQ6 | |
| VKPGAGAANPGPAEG | 786 | P78325 | |
| GAANPGPAEGAVGPK | 791 | P78325 | |
| GLGPAAPPDKAAVGA | 361 | Q96SC8 | |
| GGPGVAAEPGTPFSI | 506 | Q09019 | |
| TGAGHPASVGPKPIF | 1451 | Q5H9R4 | |
| GFPGAPGAKGEAGPT | 366 | P02458 | |
| GSKGEVGFPGLAGSP | 1186 | P02462 | |
| KKPGAGDTAFPGTGG | 166 | Q96PK6 | |
| GKPPAGALGTPAAAA | 51 | Q96IZ0 | |
| GQPGAPATPGTAGDK | 56 | P10589 | |
| LPPVFSGTPKGSGAG | 726 | Q13164 | |
| FDPLAPVTPGGAGVG | 76 | Q96DN6 | |
| SPPQAGPGGAKGTAD | 336 | Q8NHW3 | |
| GPGGCSFPLDPAAVK | 26 | Q14774 | |
| PGFGATSEGQGPLPF | 391 | Q9HCH0 | |
| GGGGPSDPSEFGTKF | 76 | Q8WXT5 | |
| PGGPEFLKTPLGGSF | 416 | Q4VC44 | |
| GGGGPSDPSEFGTKF | 76 | Q6VB84 | |
| GLGAGFPSIPVGKSP | 141 | Q9BX40 | |
| GSFSGKGGPGFPVCP | 91 | P19013 | |
| ASKEAGPKPLGSGPG | 391 | Q9UPA5 | |
| PGRQGPKGSTGFPGF | 846 | P12107 | |
| PKGSTGFPGFPGANG | 851 | P12107 | |
| PPATFPSSKGGGGSS | 36 | Q9ULD0 | |
| GTGKAPFGSPAADAP | 826 | O95206 | |
| GSLGFPGFPGASGEK | 811 | P13942 | |
| PFTPKEASGPGEGGP | 111 | Q496M5 | |
| KTGGFGAAPVFGSPP | 1966 | P35658 | |
| GAAPVFGSPPTFGGS | 1971 | P35658 | |
| GAPSVGTEGLSGPPF | 26 | P08151 | |
| GSGKPPGVPASSKSG | 336 | Q969F2 | |
| GPVRAPVAPAFGGGS | 326 | O15504 | |
| FGAAEGQPPGAAKPA | 556 | A6NF01 | |
| AFGAAEGQPPGAAKP | 971 | Q96HA1 | |
| VPASDGFPPAGGSAV | 81 | Q6UXA7 | |
| SAAFPPKTSPGGGEV | 751 | Q5T0Z8 | |
| SPAGFPPGGFIPKTA | 1096 | O14976 | |
| PGGGSRGGPEAFDPK | 26 | O00471 | |
| GGFGFVATPSPAPGV | 296 | Q96DF8 | |
| GFPGAPGPKGEIGAV | 256 | P08123 | |
| AVGPPGFAGEKGPSG | 836 | P08123 | |
| GGKTPAPGPEAASGE | 1516 | Q14674 | |
| VPATNPAPGKGTGSG | 381 | Q14781 | |
| QGPAFPEPGTATGSG | 426 | Q99704 | |
| KGETGLPGFPGSVGP | 461 | Q14993 | |
| ALCKPGGPGGPDSFT | 1191 | O00512 | |
| GTKGERGFPGSPGFP | 126 | P29400 | |
| GAPGFPGSKGEPGDI | 536 | P29400 | |
| PGSKGEPGDILTFPG | 541 | P29400 | |
| GSGGGPSAPFLVSVP | 341 | P26992 | |
| PSDKATGAPGAGPGV | 36 | Q02318 | |
| GNGDAGGPFPAVKFP | 46 | Q9NZ38 | |
| ASKPTTPTGLGGGFP | 691 | O75061 | |
| ETEPFLKGPPGGAGE | 426 | Q86UU0 | |
| GSPGFKGEAGSPGAP | 581 | Q96P44 | |
| SGLGKAEAAPPGPGV | 856 | Q7Z591 | |
| PKGSIGFPGFPGANG | 881 | P20908 | |
| PGDKGSPGSRGLPGF | 1056 | Q8NFW1 | |
| VDGGPPCAPGGTAKT | 11 | Q9NV96 | |
| GSTSPDSPGGAKGEP | 651 | Q12852 | |
| GHSKSGPDVFPATPG | 2241 | O15021 | |
| GGSPFGPAGTGKTES | 1901 | Q14204 | |
| PEDGGSGAFPPGHFK | 146 | P09038 | |
| AGFPGSPGAKGEVGP | 341 | P02461 | |
| PGFGGSFSPQIGPLS | 216 | Q17RY0 | |
| PGGAGKGRTPSAFPQ | 156 | Q9H9B1 | |
| ELSFGGIPVPGKPGT | 306 | Q8WYK1 | |
| GGGGPSDPSEFGTKF | 76 | Q5VV16 | |
| GGGGPSDPSEFGTKF | 76 | Q3SYB3 | |
| SLPSGGGGLPKQSPF | 561 | Q9NQV8 | |
| SSGFLGSKPEGPGPQ | 1581 | P48634 | |
| PRGSGSGFKPFKGGP | 1016 | Q9NWH9 | |
| SGEGPGKKPPSVFGS | 761 | Q5T8A7 | |
| TAAAKTGAPGPASGP | 31 | Q8NCN4 | |
| PGAGEPSKAGPSGAT | 341 | Q9ULL5 | |
| FGQLSGPDPPGEVGK | 126 | P0DKV0 | |
| GPPGFPGAVGAKGEA | 341 | P02452 | |
| FVPLKAGGAPVGGAA | 46 | Q3C1V1 | |
| FSPGQPVPGEKGDQG | 541 | Q17RW2 | |
| EASSKPVPAPGGGGF | 911 | Q92618 | |
| EKFGVPPAGAGFAPT | 951 | Q92618 | |
| AGGKGTPLGTPATSP | 381 | Q92574 | |
| AQPDGTPSPGGSKKG | 1281 | Q5TCY1 | |
| SGASKFPPAAEPGGL | 151 | Q5TG30 | |
| GPAEGASLTPKGGNP | 876 | Q9C0H9 | |
| QGASPLASPGGSPKG | 106 | O95935 | |
| SKPPGGFGKTSGTPA | 951 | Q5TCZ1 | |
| APAPGGAGKSEGSTP | 906 | Q8IX01 | |
| AGAPLGGSGFKGATP | 526 | C9JH25 | |
| HVSTGPEGKPGAGPS | 246 | Q9UFB7 | |
| PEAAAKGPSSAGPGE | 956 | A6NFI3 | |
| SPADLDASGAGPGPK | 576 | P52735 | |
| IDSSAFGEGKAPGPP | 441 | Q14679 | |
| GPSAGGAIAKAIGFP | 436 | Q05940 | |
| EKAPSGGGGEHPPTA | 446 | Q15849 | |
| GKPGVGPDGDFSSPG | 241 | Q9Y493 | |
| STAEGAGEKPGPAAP | 16 | Q5EBL2 | |
| DPGKAGVPGVAAPGA | 16 | P53350 | |
| SSSGGGPPKDFVLAP | 556 | Q9H5J0 |